Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

INTRODUCTION: This study aims to make an indirect comparison between enzalutamide and abiraterone acetate for mCRPC post-docetaxel. METHODS: A search for published phase 3 trials was performed with PubMed. Indirect comparisons of enzalutamide (AFFIRM) to abiraterone acetate (COU-AA-301) on outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Pui S, Haaland, Benjamin, Montero, Alberto J, Kyriakopoulos, Christos E, Lopes, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964205/
https://www.ncbi.nlm.nih.gov/pubmed/24678245
http://dx.doi.org/10.4137/CMO.S13671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964205/
https://www.ncbi.nlm.nih.gov/pubmed/24678245
http://dx.doi.org/10.4137/CMO.S13671

Ejemplares similares